LEXX
NASDAQ · Pharmaceuticals
Lexaria Bioscience Corp
$0.77
-0.02 (-2.05%)
Open$0.78
Previous Close$0.78
Day High$0.80
Day Low$0.75
52W High$1.90
52W Low$0.46
Volume—
Avg Volume145.3K
Market Cap18.04M
P/E Ratio—
EPS$-0.57
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+3,350.4% upside
Current
$0.77
$0.77
Target
$26.43
$26.43
$20.55
$26.43 avg
$40.48
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 949.1K | 680.3K | 9.47M |
| Net Income | -16,011,943 | -10,329,545 | 1.90M |
| Profit Margin | -1,686.0% | -1,601.7% | 20.1% |
| EBITDA | -15,864,245 | -10,802,833 | 3.60M |
| Free Cash Flow | — | — | 1.11M |
| Rev Growth | +39.5% | +39.5% | +1.1% |
| Debt/Equity | — | — | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |